• FirefoxInstall the new Firefox »
  •  Dow Down 1.11% Nasdaq Down 0.94%

    Intrexon Corporation (XON)

    -NYSE
    45.37 Mar 31, 4:01PM EDT
    |Pre-Market : 45.00 Down 0.37 (0.82%) 9:20AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:45.37
    Open:N/A
    Bid:45.00 x 200
    Ask:45.75 x 300
    1y Target Est:53.33
    Beta:-13.182
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:N/A - N/A
    52wk Range:13.13 - 50.98
    Volume:40
    Avg Vol (3m):1,573,260
    Market Cap:4.76B
    P/E (ttm):N/A
    EPS (ttm):-0.83
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for XON

    Comparison

    Symbol% ChgMkt Cap
    XON 0.00%4.76B
    ALXN35.03B
    BIO3.93B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):66.22
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.40
    Quarterly EPS Est (Mar-15) :-0.12
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Intrexon Corporation, a biotechnology company, operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA se... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback